Amid heightened product demand and intensified investor attention, the biotechnology sector remarkably performed during the global upheaval triggered by the COVID-19 pandemic, successfully drawing in a substantial influx of fresh capital.
Considering the ongoing momentum in the industry's expansion, fundamentally strong biotech stocks Vertex Pharmaceuticals Incorporated (VRTX), Jazz Pharmaceuticals plc (JAZZ), and Alkermes plc (ALKS), which are trading at discounts, could serve as ideal additions to your portfolio.
